Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Wellington Management Group LLP reported a 7.80% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Wellington Management Group LLP reported a 7.80% stake in Crinetics Pharmaceuticals, Inc., 8,157,204 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 8,157,204
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 7.80% | 8,157,204 |
| Wellington Group Holdings LLP | 7.80% | 8,157,204 |
| Wellington Investment Advisors Holdings LLP | 7.80% | 8,157,204 |
| Wellington Management Company LLP | 7.40% | 8,157,204 |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Wellington Management Group LLP
- Crinetics Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2025
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026